GPCR Structure Therapeutics

Watchlist

Close Nov 18 16:00 ET

1.82BMarket Cap-16442P/E (TTM)

Structure Therapeutics Stock Analyst Ratings & Price Target

Updated: Nov 9, 2024

Based on 6 analysts giving stock ratings to Structure Therapeutics in the past 3 months

Strong Buy

Updated: Nov 9, 2024

The average Structure Therapeutics stock price target is 90.17 with a max estimate of 118.00 and a min estimate of 65.00

Review Structure Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Nov 9, 2024

Strong Buy

Updated: Nov 9, 2024

Overall

No Data